Nanotechnology, bionanotechnology and microbial cell factories

Microbial Cell Factories

Volumn 9, Issue , 2010, Pages

  Villaverde, Antonio ^a,b  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b BIOMATERIALES Y NANOMEDICINA CIBER BBN   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALGINIC ACID; HYALURONIC ACID; NANOMATERIAL; NANOPARTICLE; POLYHYDROXYALKANOIC ACID; BIOLOGICAL PRODUCT;

BACTERIAL CELL; CELL SURFACE; CLINICAL EFFECTIVENESS; DRUG DELIVERY SYSTEM; EDITORIAL; GENE THERAPY; MICROBIOLOGY; MOLECULAR MECHANICS; NANOBIOTECHNOLOGY; NANOENGINEERING; NANOFABRICATION; NANOIMAGING; NONHUMAN; PARTICLE SIZE; PHAGE DISPLAY; PROTEIN ASSEMBLY; SCIENTIFIC LITERATURE; TOTAL QUALITY MANAGEMENT; VIRUS LIKE AGENT; BACTERIUM; METABOLISM; NANOMEDICINE; NANOTECHNOLOGY;

BACTERIA; BIOLOGICAL PRODUCTS; NANOMEDICINE; NANOTECHNOLOGY;

EID: 77955507118     PISSN: None     EISSN: 14752859     Source Type: Journal    
DOI: 10.1186/1475-2859-9-53     Document Type: Editorial

References (67)

1. Curtis AS, Dalby M, Gadegaard N. Cell signaling arising from nanotopography: implications for nanomedical devices. Nanomed 2006, 1:67-72.
2. Jiang W, Kim BY, Rutka JT, Chan WC. Nanoparticle-mediated cellular response is size-dependent. Nat Nanotechnol 2008, 3:145-150. 10.1038/nnano.2008.30, 18654486.
3. Sanvicens N, Marco MP. Multifunctional nanoparticles--properties and prospects for their use in human medicine. Trends Biotechnol 2008, 26:425-433. 10.1016/j.tibtech.2008.04.005, 18514941.
4. Taylor PM. Biological matrices and bionanotechnology. Philos Trans R Soc Lond B Biol Sci 2007, 362:1313-1320. 10.1098/rstb.2007.2117, 2440397, 17581810.
5. Sarikaya M, Tamerler C, Jen AK, Schulten K, Baneyx F. Molecular biomimetics: nanotechnology through biology. Nat Mater 2003, 2:577-585. 10.1038/nmat964, 12951599.
6. Zhang S, Wang ZH, Chen GQ. Microbial polyhydroxyalkanote synthesis repression protein PhaR as an affinity tag for recombinant protein purification. Microb Cell Fact 2010, 9:28. 10.1186/1475-2859-9-28, 2873406, 20459707.
7. Vazquez JA, Montemayor MI, Fraguas J, Murado MA. Hyaluronic acid production by Streptococcus zooepidemicus in marine by-products media from mussel processing wastewaters and tuna peptone viscera. Microb Cell Fact 2010, 9:46. 10.1186/1475-2859-9-46, 2901256, 20546615.
8. Singh M, Patel SK, Kalia VC. Bacillus subtilis as potential producer for polyhydroxyalkanoates. Microb Cell Fact 2009, 8:38. 10.1186/1475-2859-8-38, 2719590, 19619289.
9. Galindo E, Pena C, Nunez C, Segura D, Espin G. Molecular and bioengineering strategies to improve alginate and polydydroxyalkanoate production by Azotobacter vinelandii. Microb Cell Fact 2007, 6:7. 10.1186/1475-2859-6-7, 1805506, 17306024.
10. Shao X, Jiang M, Yu Z, Cai H, Li L. Surface display of heterologous proteins in Bacillus thuringiensis using a peptidoglycan hydrolase anchor. Microb Cell Fact 2009, 8:48. 10.1186/1475-2859-8-48, 2754439, 19754974.
11. Rutherford N, Mourez M. Surface display of proteins by gram-negative bacterial autotransporters. Microb Cell Fact 2006, 5:22. 10.1186/1475-2859-5-22, 1533851, 16787545.
12. Hinc K, Isticato R, Dembek M, Karczewska J, Iwanicki A, Peszynska-Sularz G, et al. Expression and display of UreA of Helicobacter acinonychis on the surface of Bacillus subtilis spores. Microb Cell Fact 2010, 9:2. 10.1186/1475-2859-9-2, 2841587, 20082702.
13. Martinez-Alonso M, Gonzalez-Montalban N, Garcia-Fruitos E, Villaverde A. Learning about protein solubility from bacterial inclusion bodies. Microb Cell Fact 2009, 8:4. 10.1186/1475-2859-8-4, 2630952, 19133126.
14. Garcia-Fruitos E, Gonzalez-Montalban N, Morell M, Vera A, Ferraz RM, Aris A, et al. Aggregation as bacterial inclusion bodies does not imply inactivation of enzymes and fluorescent proteins. Microb Cell Fact 2005, 4:27. 10.1186/1475-2859-4-27, 1224866, 16156893.
15. de Marco A. Strategies for successful recombinant expression of disulfide bond-dependent proteins in Escherichia coli. Microb Cell Fact 2009, 8:26. 10.1186/1475-2859-8-26, 2689190, 19442264.
16. Kolaj O, Spada S, Robin S, Wall JG. Use of folding modulators to improve heterologous protein production in Escherichia coli. Microb Cell Fact 2009, 8:9. 10.1186/1475-2859-8-9, 2642769, 19173718.
17. Sorensen HP, Mortensen KK. Soluble expression of recombinant proteins in the cytoplasm of Escherichia coli. Microb Cell Fact 2005, 4:1. 10.1186/1475-2859-4-1, 544838, 15629064.
18. Ferrer-Miralles N, Domingo-Espin J, Corchero JL, Vazquez E, Villaverde A. Microbial factories for recombinant pharmaceuticals. Microb Cell Fact 2009, 8:17. 10.1186/1475-2859-8-17, 2669800, 19317892.
19. Gasser B, Saloheimo M, Rinas U, Dragosits M, Rodriguez-Carmona E, Baumann K, et al. Protein folding and conformational stress in microbial cells producing recombinant proteins: a host comparative overview. Microb Cell Fact 2008, 7:11. 10.1186/1475-2859-7-11, 2322954, 18394160.
20. Gurramkonda C, Adnan A, Gabel T, Lunsdorf H, Ross A, Nemani SK, et al. Simple high-cell density fed-batch technique for high-level recombinant protein production with Pichia pastoris: Application to intracellular production of Hepatitis B surface antigen. Microb Cell Fact 2009, 8:13. 10.1186/1475-2859-8-13, 2646686, 19208244.
21. Scheibel T. Spider silks: recombinant synthesis, assembly, spinning, and engineering of synthetic proteins. Microb Cell Fact 2004, 3:14. 10.1186/1475-2859-3-14, 534800, 15546497.
22. Peternel S, Grdadolnik J, Gaberc-Porekar V, Komel R. Engineering inclusion bodies for non denaturing extraction of functional proteins. Microb Cell Fact 2008, 7:34. 10.1186/1475-2859-7-34, 2630956, 19046444.
23. Sabate R, Espargaro A, Saupe SJ, Ventura S. Characterization of the amyloid bacterial inclusion bodies of the HET-s fungal prion. Microb Cell Fact 2009, 8:56. 10.1186/1475-2859-8-56, 2774669, 19863787.
24. Parrilli E, Giuliani M, Marino G, Tutino ML. Influence of production process design on inclusion bodies protein: the case of an Antarctic flavohemoglobin. Microb Cell Fact 2010, 9:19. 10.1186/1475-2859-9-19, 2857821, 20334669.
25. Jurgen B, Breitenstein A, Urlacher V, Buttner K, Lin H, Hecker M, et al. Quality control of inclusion bodies in Escherichia coli. Microb Cell Fact 2010, 9:41. 10.1186/1475-2859-9-41, 2893105, 20509924.
26. Lethanh H, Neubauer P, Hoffmann F. The small heat-shock proteins IbpA and IbpB reduce the stress load of recombinant Escherichia coli and delay degradation of inclusion bodies. Microb Cell Fact 2005, 4:6. 10.1186/1475-2859-4-6, 552319, 15707488.
27. Petty NK, Evans TJ, Fineran PC, Salmond GP. Biotechnological exploitation of bacteriophage research. Trends Biotechnol 2007, 25:7-15. 10.1016/j.tibtech.2006.11.003, 17113664.
28. Deutscher SL. Phage display in molecular imaging and diagnosis of cancer. Chem Rev 2010, 110:3196-3211. 10.1021/cr900317f, 20170129.
29. Balestrieri ML, Napoli C. Novel challenges in exploring peptide ligands and corresponding tissue-specific endothelial receptors. Eur J Cancer 2007, 43:1242-1250. 10.1016/j.ejca.2007.02.006, 17449238.
30. Aina OH, Liu R, Sutcliffe JL, Marik J, Pan CX, Lam KS. From combinatorial chemistry to cancer-targeting peptides. Mol Pharm 2007, 4:631-651. 10.1021/mp700073y, 17880166.
31. Sidhu SS. Phage display in pharmaceutical biotechnology. Curr Opin Biotechnol 2000, 11:610-616. 10.1016/S0958-1669(00)00152-X, 11102798.
32. Sarikaya M, Tamerler C, Jen AK, Schulten K, Baneyx F. Molecular biomimetics: nanotechnology through biology. Nat Mater 2003, 2:577-585. 10.1038/nmat964, 12951599.
33. Tamerler C, Sarikaya M. Molecular biomimetics: nanotechnology and bionanotechnology using genetically engineered peptides. Philosophical Transactions of the Royal Society A-Mathematical Physical and Engineering Sciences 2009, 367:1705-1726.
34. Mao C, Solis DJ, Reiss BD, Kottmann ST, Sweeney RY, Hayhurst A, et al. Virus-based toolkit for the directed synthesis of magnetic and semiconducting nanowires. Science 2004, 303:213-217. 10.1126/science.1092740, 14716009.
35. Steinmetz NF, Bize A, Findlay KC, Lomonossoff GP, Manchester M, Evans DJ, et al. Site-specific and Spatially Controlled Addressability of a New Viral Nanobuilding Block: Sulfolobus islandicus Rod-shaped Virus 2. Advanced Functional Materials 2008, 18:3478-3486.
36. Steinmetz NF, Shah SN, Barclay JE, Rallapalli G, Lomonossoff GP, Evans DJ. Virus-templated silica nanoparticles. Small 2009, 5:813-816. 10.1002/smll.200801348, 19197969.
37. Edelstein ML, Abedi MR, Wixon J. Gene therapy clinical trials worldwide to 2007--an update. J Gene Med 2007, 9:833-842. 10.1002/jgm.1100, 17721874.
38. Evans DJ. Exploitation of plant and archaeal viruses in bionanotechnology. Biochem Soc Trans 2009, 37:665-670. 10.1042/BST0370665, 19614572.
39. Lee TJ, Schwartz C, Guo P. Construction of bacteriophage phi29 DNA packaging motor and its applications in nanotechnology and therapy. Ann Biomed Eng 2009, 37:2064-2081. 10.1007/s10439-009-9723-0, 2855900, 19495981.
40. Bundy BC, Franciszkowicz MJ, Swartz JR. Escherichia coli-based cell-free synthesis of virus-like particles. Biotechnol Bioeng 2008, 100:28-37. 10.1002/bit.21716, 18023052.
41. Martel S, Felfoul O, Mohammadi M, Mathieu JB. Interventional procedure based on nanorobots propelled and steered by flagellated magnetotactic bacteria for direct targeting of tumors in the human body. Conf Proc IEEE Eng Med Biol Soc 2008, 2008:2497-2500.
42. Deplanche K, Woods RD, Mikheenko IP, Sockett RE, Macaskie LE. Manufacture of stable palladium and gold nanoparticles on native and genetically engineered flagella scaffolds. Biotechnol Bioeng 2008, 101:873-880. 10.1002/bit.21966, 18819156.
43. van den Heuvel MG, Dekker C. Motor proteins at work for nanotechnology. Science 2007, 317:333-336. 10.1126/science.1139570, 17641191.
44. Garcia-Fruitos E, Seras-Franzoso J, Vazquez E, Villaverde A. Tunable geometry of bacterial inclusion bodies as substrate materials for tissue engineering. Nanotechnology 2010, 21:205101. 10.1088/0957-4484/21/20/205101, 20413834.
45. Diez-Gil C, Krabbenborg S, Garcia-Fruitos E, Vazquez E, Rodriguez-Carmona E, Ratera I, et al. The nanoscale properties of bacterial inclusion bodies and their effect on mammalian cell proliferation. Biomaterials 2010, 31:5805-5812. 10.1016/j.biomaterials.2010.04.008, 20452667.
46. Garcia-Fruitos E, Rodriguez-Carmona E, Diez-Gil C, Ferraz RM, Vazquez E, Corchero JL, et al. Surface Cell Growth Engineering Assisted by a Novel Bacterial Nanomaterial. Advanced Materials 2009, 21:4249-4253.
47. Garcia-Fruitos E, Villaverde A. Friendly production of bacterial inclusion bodies. Korean Journal of Chemical Engineering 2010, 27:385-389.
48. Corchero JL, Villaverde A. Biomedical applications of distally controlled magnetic nanoparticles. Trends Biotechnol 2009, 27:468-476. 10.1016/j.tibtech.2009.04.003, 19564057.
49. Ding Y, Li J, Liu J, Yang J, Jiang W, Tian J, et al. Deletion of the ftsZ-like gene results in the production of superparamagnetic magnetite magnetosomes in Magnetospirillum gryphiswaldense. J Bacteriol 2010, 192:1097-1105. 10.1128/JB.01292-09, 20023033.
50. Ohuchi S, Schuler D. In vivo display of a multisubunit enzyme complex on biogenic magnetic nanoparticles. Appl Environ Microbiol 2009, 75:7734-7738. 10.1128/AEM.01640-09, 2794094, 19837839.
51. Sun JB, Duan JH, Dai SL, Ren J, Guo L, Jiang W, et al. Preparation and anti-tumor efficiency evaluation of doxorubicin-loaded bacterial magnetosomes: magnetic nanoparticles as drug carriers isolated from Magnetospirillum gryphiswaldense. Biotechnol Bioeng 2008, 101:1313-1320. 10.1002/bit.22011, 18980188.
52. Sun JB, Zhao F, Tang T, Jiang W, Tian JS, Li Y, et al. High-yield growth and magnetosome formation by Magnetospirillum gryphiswaldense MSR-1 in an oxygen-controlled fermentor supplied solely with air. Appl Microbiol Biotechnol 2008, 79:389-397. 10.1007/s00253-008-1453-y, 18425510.
53. Lang C, Schuler D, Faivre D. Synthesis of Magnetite Nanoparticles for Bio- and Nanotechnology: Genetic Engineering and Biomimetics of Bacterial Magnetosomes. Macromol Biosci 2007, 7:144-151. 10.1002/mabi.200600235, 17295401.
54. Vaidyanathan R, Gopalram S, Kalishwaralal K, Deepak V, Pandian SR, Gurunathan S. Enhanced silver nanoparticle synthesis by optimization of nitrate reductase activity. Colloids Surf B Biointerfaces 2010, 75:335-341. 10.1016/j.colsurfb.2009.09.006, 19796922.
55. Gurunathan S, Kalishwaralal K, Vaidyanathan R, Venkataraman D, Pandian SR, Muniyandi J, et al. Biosynthesis, purification and characterization of silver nanoparticles using Escherichia coli. Colloids Surf B Biointerfaces 2009, 74:328-335. 10.1016/j.colsurfb.2009.07.048, 19716685.
56. Chen YL, Tuan HY, Tien CW, Lo WH, Liang HC, Hu YC. Augmented biosynthesis of cadmium sulfide nanoparticles by genetically engineered Escherichia coli. Biotechnol Prog 2009, 25:1260-1266. 10.1002/btpr.199, 19630084.
57. Kalishwaralal K, Deepak V, Pandian SRK, Gurunathan S. Biological synthesis of gold nanocubes from Bacillus licheniformis. Bioresource Technology 2009, 100:5356-5358. 10.1016/j.biortech.2009.05.051, 19574037.
58. Kalimuthu K, Suresh BR, Venkataraman D, Bilal M, Gurunathan S. Biosynthesis of silver nanocrystals by Bacillus licheniformis. Colloids Surf B Biointerfaces 2008, 65:150-153. 10.1016/j.colsurfb.2008.02.018, 18406112.
59. Husseiny MI, El-Aziz MA, Badr Y, Mahmoud MA. Biosynthesis of gold nanoparticles using Pseudomonas aeruginosa. Spectrochim Acta A Mol Biomol Spectrosc 2007, 67:1003-1006. 10.1016/j.saa.2006.09.028, 17084659.
60. Gericke M, Pinches A. Microbial production of gold nanoparticles. Gold Bulletin 2006, 39:22-28.
61. Chen CQ. A microbial polyhydroxyalkanoates (PHA) based bio- and materials industry. Chem Soc Rev 2009, 38(8):2434-2446. Ref Type: Generic, 10.1039/b812677c, 19623359.
62. Atwood JA, Rehm BH. Protein engineering towards biotechnological production of bifunctional polyester beads. Biotechnol Lett 2009, 31:131-137. 10.1007/s10529-008-9836-9, 18800192.
63. Ossipov DA. Nanostructured hyaluronic acid-based materials for active delivery to cancer. Expert Opin Drug Deliv 2010, 7(6):681-703. 10.1517/17425241003730399, 20367530.
64. Ibrahim HK, El-Leithy IS, Makky AA. Mucoadhesive Nanoparticles as Carrier Systems for Prolonged Ocular Delivery of Gatifloxacin/Prednisolone Bitherapy. Mol Pharm 2010, 7:576-585. 10.1021/mp900279c, 20163167.
65. Mellors R, Benzeval I, Eisenthal R, Hubble J. Preparation of self-assembled microspheres and their potential for drug delivery. Pharmaceutical Development and Technology 2010, 15:105-111. 10.3109/10837450903036163, 19545194.
66. Yao YC, Zhan XY, Zhang J, Zou XH, Wang ZH, Xiong YC, et al. A specific drug targeting system based on polyhydroxyalkanoate granule binding protein PhaP fused with targeted cell ligands. Biomaterials 2008, 29:4823-4830. 10.1016/j.biomaterials.2008.09.008, 18824258.
67. Grage K, Jahns AC, Parlane N, Palanisamy R, Rasiah IA, Atwood JA, et al. Bacterial Polyhydroxyalkanoate Granules: Biogenesis, Structure, and Potential Use as Nano-/Micro-Beads in Biotechnological and Biomedical Applications. Biomacromolecules 2009, 10:660-669. 10.1021/bm801394s, 19275166.